TG Therapeutics to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform
if (g_displayableSlots.mobileTopLeaderboard) {
pushDisplayAd(function() { googletag.display('div-gpt-mobile-top-leaderboard'); });
}
From MaxCyte, Inc.Feb 13 2025
MaxCyte, Inc., a leading, cell-engineering…
Read More...
Read More...